This news is delayed by 15 minutes, sign up now to get live news & full features.
DMAC DIAMEDICA THERAPEUTICS INC
+ add to watchlist
$6.14
diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.
Mkt Cap: $277.57M
52 Week High: $6.82
P/E: 0.00
52 Week Low: $3.19
Dividend: $0.00
Shares Outstanding: 51.69M